NCT02107872View on ClinicalTrials.gov

Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500

PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Metabolic Disorders
Interventions
DRUG

REGN1500

DRUG

placebo

Trial Locations (4)

Unknown

Daytona Beach

Evansville

Dallas

San Antonio

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT02107872 - Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500 | Biotech Hunter | Biotech Hunter